capsaicin has been researched along with Psoriasis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TC; Chang, WY; Huang, WC; Krueger, JG; Lee, MS; Tsai, TF | 1 |
| Agrawal, U; Gupta, M; Vyas, SP | 1 |
| Agrawal, U; Gupta, M; Gupta, R; Mangal, S; Vyas, SP | 1 |
| Boakye, CH; Godugu, C; Mendonca Faria, HA; Patel, AR; Singh, M; Somagoni, J; Zucolotto, V | 1 |
| Anand, P; Anand, U; Boyce, B; Mainero, V; Robinson, J; Roblin, D; Sandy, J; Wickramasinghe, R; Yosipovitch, G | 1 |
| Alban, J; Farahnik, B; Sharma, D; Sivamani, RK | 1 |
| Frlickova, Z; Pec, J; Pecova, R; Tatar, M | 1 |
| Dawn, A; Yosipovitch, G | 1 |
| Brodecka, H; Glinska-Ferenz, M; Glinski, W; Kowalski, D | 1 |
| Berberian, B; Dodd, WA; Ellis, CN; Jarratt, MT; Katz, HI; Krueger, G; Prawer, S; Rex, IH; Sulica, VI; Wolf, JE | 1 |
| Li Wan Po, A; Zhang, WY | 1 |
| Arnold, WP; van de Kerkhof, PC | 1 |
| Krogstad, AL; Larson, G; Lönnroth, P; Wallin, BG | 1 |
| Alexacos, N; Letourneau, R; Pang, X; Singh, LK; Theoharides, TC | 1 |
| Johansson, O | 1 |
| Glinska-Ferenz, M; Glinski, W; Pierozynska-Dubowska, M | 1 |
| Alaybeyi, F; Kürkçüoğlu, N | 1 |
| Bernstein, JE | 1 |
| Bernstein, JE; Parish, LC; Rapaport, M; Roenigk, HH; Rosenbaum, MM | 1 |
3 review(s) available for capsaicin and Psoriasis
| Article | Year |
|---|---|
Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review.
Topics: Administration, Cutaneous; Capsaicin; Clinical Trials as Topic; Dermatologic Agents; Drugs, Chinese Herbal; Evidence-Based Medicine; Humans; Mahonia; Phytotherapy; Plant Extracts; Plant Preparations; Psoriasis; Treatment Outcome | 2017 |
Treating itch in psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antipruritics; Capsaicin; Coal Tar; Emollients; Histamine H1 Antagonists; Humans; Immunologic Factors; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Mianserin; Mirtazapine; Morpholines; Phototherapy; Pruritus; Psoriasis; Quality of Life; Salicylates; Skin Care; Vitamin D | 2006 |
The effectiveness of topically applied capsaicin. A meta-analysis.
Topics: Administration, Topical; Capsaicin; Diabetic Neuropathies; Humans; Osteoarthritis; Pain; Psoriasis | 1994 |
6 trial(s) available for capsaicin and Psoriasis
| Article | Year |
|---|---|
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
Topics: Administration, Topical; Adult; Biopsy, Needle; Capsaicin; Cells, Cultured; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Protein Kinase Inhibitors; Pruritus; Psoriasis; Receptor, trkA; Treatment Outcome | 2015 |
Cough sensitivity in atopic dermatitis.
Topics: Adult; Capsaicin; Case-Control Studies; Cough; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psoriasis | 2003 |
A double-blind evaluation of topical capsaicin in pruritic psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pruritus; Psoriasis; Substance P | 1993 |
Capsaicin treatment induces histamine release and perfusion changes in psoriatic skin.
Topics: Adult; Analysis of Variance; Capsaicin; Electric Stimulation; Female; Histamine Release; Humans; Male; Microdialysis; Middle Aged; Psoriasis; Regional Blood Flow; Skin; Vasoconstrictor Agents | 1999 |
Topical capsaicin for psoriasis.
Topics: Administration, Topical; Adult; Capsaicin; Female; Humans; Male; Ointments; Psoriasis | 1990 |
Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis | 1986 |
10 other study(ies) available for capsaicin and Psoriasis
| Article | Year |
|---|---|
Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Antipruritics; Capsaicin; Dermatitis; Disease Models, Animal; Epidermis; Female; Hyperplasia; Imiquimod; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2021 |
Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis.
Topics: Administration, Cutaneous; Animals; Antipruritics; Biological Transport; Capsaicin; Drug Carriers; Microscopy, Electron, Transmission; Nanoparticles; Oleic Acid; Particle Size; Phosphatidylcholines; Psoriasis; Rabbits; Rats; Skin; Skin Absorption; Tissue Culture Techniques | 2015 |
Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy.
Topics: Administration, Topical; Animals; Capsaicin; Drug Delivery Systems; Emulsions; Liposomes; Psoriasis; Rats; Skin Absorption | 2016 |
Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Capsaicin; Cell Proliferation; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Emulsions; Gels; Humans; Imiquimod; Immunohistochemistry; In Vitro Techniques; Inflammation; Keratinocytes; Micelles; Microdialysis; Microscopy, Atomic Force; Nanoparticles; Organ Size; Permeability; Psoriasis; Rats; Rheology; Skin Absorption; Spleen | 2014 |
Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease.
Topics: beta-Endorphin; Capsaicin; Dermatitis, Atopic; Humans; Neuropeptides; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1994 |
Topical capsaicin in pruritic psoriasis.
Topics: Administration, Topical; Capsaicin; Humans; Pruritus; Psoriasis | 1994 |
Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
Topics: Acute Disease; Animals; Antibodies; Capsaicin; Cell Degranulation; Corticotropin-Releasing Hormone; Male; Mast Cells; Microscopy, Electron; Microtomy; Neurogenic Inflammation; Neuroimmunomodulation; Neuropeptides; Neurotensin; Psoriasis; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Restraint, Physical; Skin; Stress, Physiological; Substance P; Urticaria | 1999 |
"Neurogenic inflammation induced by capsaicin in patients with psoriasis"--is really only "neuropeptides" the key word?
Topics: Capsaicin; Drug Eruptions; Erythema; Humans; Neuropeptides; Psoriasis | 1992 |
Neurogenic inflammation induced by capsaicin in patients with psoriasis.
Topics: Administration, Cutaneous; Adult; Age Factors; Capsaicin; Dose-Response Relationship, Drug; Erythema; Forearm; Humans; Inflammation; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1991 |
Capsaicin in the treatment of dermatologic disease.
Topics: Capsaicin; Herpes Zoster; Humans; Neuralgia; Ointments; Psoriasis; Substance P | 1987 |